tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SE:CINPHA Stock Latest News

Cinclus Pharma Secures Up to EUR 28 Million to Accelerate Late-Stage Acid-Reflux Drug
Company AnnouncementsCinclus Pharma Secures Up to EUR 28 Million to Accelerate Late-Stage Acid-Reflux Drug
4d ago
Cinclus Pharma Gains Boost as FDA Backs Single Pivotal Study Path for GERD Drug
PremiumCompany Announcements
Cinclus Pharma Gains Boost as FDA Backs Single Pivotal Study Path for GERD Drug
22d ago
Cinclus Pharma Boosts 2025 Revenue but Maintains Heavy R&D-Driven Losses
PremiumCompany Announcements
Cinclus Pharma Boosts 2025 Revenue but Maintains Heavy R&D-Driven Losses
27d ago
Cinclus Pharma Wins FDA Backing for Linaprazan Glurate Nonclinical Plan
PremiumCompany Announcements
Cinclus Pharma Wins FDA Backing for Linaprazan Glurate Nonclinical Plan
1M ago
Cinclus Pharma Gains EMA Backing on Manufacturing Plan for GERD Drug
PremiumCompany Announcements
Cinclus Pharma Gains EMA Backing on Manufacturing Plan for GERD Drug
1M ago
Cinclus Pharma Sets Date for Fourth-Quarter 2025 Report and Investor Presentation
PremiumCompany AnnouncementsCinclus Pharma Sets Date for Fourth-Quarter 2025 Report and Investor Presentation
1M ago
Cinclus Pharma Confirms Seven-Member Board and Appoints New Director at Extraordinary Meeting
Premium
Company Announcements
Cinclus Pharma Confirms Seven-Member Board and Appoints New Director at Extraordinary Meeting
2M ago
Cinclus Pharma Advances Phase 3 GERD Maintenance Trial: Why Linaprazan Glurate Matters for Investors
Premium
Company Announcements
Cinclus Pharma Advances Phase 3 GERD Maintenance Trial: Why Linaprazan Glurate Matters for Investors
2M ago
Cinclus Pharma’s Linaprazan Glurate Gains China Reimbursement Listing
PremiumCompany Announcements
Cinclus Pharma’s Linaprazan Glurate Gains China Reimbursement Listing
3M ago
Cinclus Pharma Appoints New CFO Amidst Strategic Advancements
PremiumCompany Announcements
Cinclus Pharma Appoints New CFO Amidst Strategic Advancements
3M ago
Cinclus Pharma Announces Extraordinary General Meeting
PremiumCompany Announcements
Cinclus Pharma Announces Extraordinary General Meeting
3M ago
Cinclus Pharma Proposes New Board Member Amidst Strategic Milestone
PremiumCompany Announcements
Cinclus Pharma Proposes New Board Member Amidst Strategic Milestone
4M ago
Cinclus Pharma Hosts Event on GERD Treatment Advancements
PremiumCompany AnnouncementsCinclus Pharma Hosts Event on GERD Treatment Advancements
4M ago
Cinclus Pharma Reports Q3 2025 Financial Results Amidst Continued R&D Investment
Premium
Company Announcements
Cinclus Pharma Reports Q3 2025 Financial Results Amidst Continued R&D Investment
4M ago
Cinclus Pharma Reports Increased Sales but Faces Financial Challenges in 2025
Premium
Company Announcements
Cinclus Pharma Reports Increased Sales but Faces Financial Challenges in 2025
4M ago
Cinclus Pharma Appoints 2026 AGM Nomination Committee
PremiumCompany Announcements
Cinclus Pharma Appoints 2026 AGM Nomination Committee
4M ago
Cinclus Pharma Holding AB: Promising Growth Potential with Linaprazan Glurate and Strategic Partnerships
PremiumRatings
Cinclus Pharma Holding AB: Promising Growth Potential with Linaprazan Glurate and Strategic Partnerships
4M ago
Cinclus Pharma Highlights Need for New GERD Treatments at ISPOR Conference
PremiumCompany Announcements
Cinclus Pharma Highlights Need for New GERD Treatments at ISPOR Conference
4M ago
Cinclus Pharma to Release Q3 2025 Financial Report
PremiumCompany Announcements
Cinclus Pharma to Release Q3 2025 Financial Report
4M ago
Cinclus Pharma to Engage Investors at Key Conferences in November
PremiumCompany AnnouncementsCinclus Pharma to Engage Investors at Key Conferences in November
4M ago
Cinclus Pharma Gains FDA Support for Linaprazan Glurate Development
Premium
Company Announcements
Cinclus Pharma Gains FDA Support for Linaprazan Glurate Development
5M ago
Cinclus Pharma Initiates Phase III Trial for GERD Treatment
Premium
Company Announcements
Cinclus Pharma Initiates Phase III Trial for GERD Treatment
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >